English
Support
Instant account opening
Trading Platform
Deposit/Withdraw
Login
For Traders
For Beginners
For Partners
Company Services
Take a Break
About InstaTrade
Account Opening
Instant Account Opening
Account Verification
Make a deposit
See also
Dividend calculator
Trader calculator
Trading Conditions
Trading Platform
Account Types
Trading Instruments
Web Trading Platform
Segregated accounts
Insta Futures
VPS hosting
Stocks for crypto
Analytics
Market review
Cryptocurrencies
Analytics
Chief Strategist
Economic Calendar
Holidays worldwide
Video analytics
Trading Sessions
News in pictures
Blog
Charts
Currencies
US and EU stocks
Crypto CFD
Metals and commodities
IPO markets
Open Demo Account
Training
Trading Platform
FAQ
How to start trading
Trading Glossary
See also
Main Page
Partner Area
Advantages for Affiliates
Registration
Bonuses
100% Bonus
55% Bonus
30% Bonus
Club Bonus
PAMM System
TOP 5
Monitoring
Registration
InstaCopy System
TOP 5
Monitoring
Registration
Smart Investments
Events
Trading On Top
InstaTrade Balloon
7 000 000 Clients
Forums
Trading humour
Trading Portal
Why Choose Us
InstaSport
Awards
InstaTrade Stars
Documents
For Traders
Trading Conditions
Trading Instruments
ALNY
ALNY
Alnylam Pharmaceuticals Inc.
391.65
-1.4
(
-0.36
%)
16 Dec 2025 20:59
Buy
391.65
Sell
390.15
50%
Traders' feedback
50%
Closing
398.32
Maximum
price
398.69
One week
high
431.61
52-week
high
495.03
Opening
394.79
Minimum
price
387.92
One week
low
386.11
52-week
low
205.03
About
Overview
Technical
Company Info
Financials
Quarterly Earnings
Yearly Earnings
Symbol
ALNY
Name
Alnylam Pharmaceuticals, Inc.
Country
United States
State
MA
City
Cambridge
Address
675 West Kendall Street, Henri A. Termeer Square
Industry
Biotechnology
Sector
Healthcare
Website
https://www.alnylam.com
Full-time Employees
2230
Market Cap (USD)
$ 63 136 829 440
Average Daily Volume (3M)
$ 1 184 487
Average Daily Volume (10D)
$ 1 111 320
Dividend Rate
-
Dividend Yield
-
Payout Ratio
0.00%
Volume
1029195
Trailing P/E
-
Beta
0.353
Book Value
1.913
Price to Book
251.78778
Enterprise Value
$ 63 018 979 328
Enterprise to Revenue
25.597
Enterprise to EBITDA
-509.504
Net Income to Common
$ -319 088 992
Profit Margins
-12.96%
Trailing EPS
-2.46
Debt to Equity
1093.309
EBITDA
$ -123 687 000
Gross Profits
$ 2 059 246 976
Return on Equity
-257.83%
Total Debt
$ 2 739 734 016
Total Revenue
$ 2 461 963 008
S&P 500
13.84%
1Q2025
2Q2025
3Q2024
4Q2024
Earnings
$ -1 287 000
$ 44 122 000
$ -64 199 000
$ 8 048 000
Revenue
$ 594 189 000
$ 773 689 000
$ 500 919 000
$ 593 166 000
1Q2025
Earnings
$ -1 287 000
Revenue
$ 594 189 000
2Q2025
Earnings
$ 44 122 000
Revenue
$ 773 689 000
3Q2024
Earnings
$ -64 199 000
Revenue
$ 500 919 000
4Q2024
Earnings
$ 8 048 000
Revenue
$ 593 166 000
2021
2022
2023
2024
Earnings
$ -727 507 000
$ -790 609 000
$ -201 618 000
$ -3 051 000
Revenue
$ 844 287 000
$ 1 037 418 000
$ 1 828 292 000
$ 2 248 243 000
2021
Earnings
$ -727 507 000
Revenue
$ 844 287 000
2022
Earnings
$ -790 609 000
Revenue
$ 1 037 418 000
2023
Earnings
$ -201 618 000
Revenue
$ 1 828 292 000
2024
Earnings
$ -3 051 000
Revenue
$ 2 248 243 000
Currencies
Shares
Indices
Metals
Oil and gas
Commodity futures
Cryptocurrencies
InstaFutures
See all tools
[quote_name]
[quote_desc]
-
Nothing found
[type_head]
Show more
Can't speak right now?
Ask your question in the
chat
.
